# Safety and Efficacy of the BTL-703 Treatment for the Non-invasive Lipolysis

> **NCT03545360** · NA · UNKNOWN · sponsor: **BTL Industries Ltd.** · enrollment: 52 (estimated)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DEVICE:** BTL-703 (Treatment group)

## Key facts

- **NCT ID:** NCT03545360
- **Lead sponsor:** BTL Industries Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2019-01-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2018-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03545360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03545360, "Safety and Efficacy of the BTL-703 Treatment for the Non-invasive Lipolysis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03545360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*